Injective rebounds from August low, eyes $15 target as bullish signals strengthen
Covered by 1 source · 1 article
🚀 Injective surges past $5.90, analysts set sights on a $15 target for $INJ. 📊 Bullish momentum grows with key EMA alignment and MACD signals. 💡 Over $1 billion in tokenized real estate mortgages boost INJ’s real-world asset narrative. �…
Covered by
